Annual EBITDA
-$29.47 M
-$6.24 M-26.84%
December 31, 2023
Summary
- As of March 2, 2025, NKGNW annual EBITDA is -$29.47 million, with the most recent change of -$6.24 million (-26.84%) on December 31, 2023.
- During the last 3 years, NKGNW annual EBITDA has fallen by -$8.77 million (-42.34%).
- NKGNW annual EBITDA is now -42.34% below its all-time high of -$20.70 million, reached on December 31, 2021.
Performance
NKGNW EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$7.13 M
+$1.39 M+16.31%
June 30, 2024
Summary
- As of March 2, 2025, NKGNW quarterly EBITDA is -$7.13 million, with the most recent change of +$1.39 million (+16.31%) on June 30, 2024.
- Over the past year, NKGNW quarterly EBITDA has dropped by -$2.27 million (-46.67%).
- NKGNW quarterly EBITDA is now -46.67% below its all-time high of -$4.86 million, reached on September 30, 2023.
Performance
NKGNW Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$29.65 M
-$926.00 K-3.22%
June 30, 2024
Summary
- As of March 2, 2025, NKGNW TTM EBITDA is -$29.65 million, with the most recent change of -$926.00 thousand (-3.22%) on June 30, 2024.
- Over the past year, NKGNW TTM EBITDA has dropped by -$13.00 million (-78.10%).
- NKGNW TTM EBITDA is now -395.42% below its all-time high of -$5.98 million, reached on September 30, 2022.
Performance
NKGNW TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
NKGNW EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -26.8% | -46.7% | -78.1% |
| 3 y3 years | -42.3% | -19.2% | -395.4% |
| 5 y5 years | -42.3% | -19.2% | -395.4% |
NKGNW EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -42.3% | at low | -46.7% | +21.9% | -395.4% | at low |
| 5 y | 5-year | -42.3% | at low | -46.7% | +21.9% | -395.4% | at low |
| alltime | all time | -42.3% | at low | -46.7% | +21.9% | -395.4% | at low |
NKGen Biotech Warrants EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2024 | - | -$7.13 M(-16.3%) | -$29.65 M(+3.2%) |
| Mar 2024 | - | -$8.52 M(-6.7%) | -$28.72 M(+42.2%) |
| Dec 2023 | -$29.47 M | -$9.13 M(+87.8%) | -$20.20 M(+21.3%) |
| Sep 2023 | - | -$4.86 M(-21.6%) | -$16.65 M(-6.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | -$6.21 M(+11.2%) | -$17.77 M(+53.7%) |
| Dec 2022 | -$23.23 M(+12.2%) | -$5.58 M(-6.8%) | -$11.56 M(+93.2%) |
| Sep 2022 | - | -$5.98 M | -$5.98 M |
| Dec 2021 | -$20.70 M | - | - |
FAQ
- What is NKGen Biotech Warrants annual EBITDA?
- What is the all time high annual EBITDA for NKGen Biotech Warrants?
- What is NKGen Biotech Warrants annual EBITDA year-on-year change?
- What is NKGen Biotech Warrants quarterly EBITDA?
- What is the all time high quarterly EBITDA for NKGen Biotech Warrants?
- What is NKGen Biotech Warrants quarterly EBITDA year-on-year change?
- What is NKGen Biotech Warrants TTM EBITDA?
- What is the all time high TTM EBITDA for NKGen Biotech Warrants?
- What is NKGen Biotech Warrants TTM EBITDA year-on-year change?
What is NKGen Biotech Warrants annual EBITDA?
The current annual EBITDA of NKGNW is -$29.47 M
What is the all time high annual EBITDA for NKGen Biotech Warrants?
NKGen Biotech Warrants all-time high annual EBITDA is -$20.70 M
What is NKGen Biotech Warrants annual EBITDA year-on-year change?
Over the past year, NKGNW annual EBITDA has changed by -$6.24 M (-26.84%)
What is NKGen Biotech Warrants quarterly EBITDA?
The current quarterly EBITDA of NKGNW is -$7.13 M
What is the all time high quarterly EBITDA for NKGen Biotech Warrants?
NKGen Biotech Warrants all-time high quarterly EBITDA is -$4.86 M
What is NKGen Biotech Warrants quarterly EBITDA year-on-year change?
Over the past year, NKGNW quarterly EBITDA has changed by -$2.27 M (-46.67%)
What is NKGen Biotech Warrants TTM EBITDA?
The current TTM EBITDA of NKGNW is -$29.65 M
What is the all time high TTM EBITDA for NKGen Biotech Warrants?
NKGen Biotech Warrants all-time high TTM EBITDA is -$5.98 M
What is NKGen Biotech Warrants TTM EBITDA year-on-year change?
Over the past year, NKGNW TTM EBITDA has changed by -$13.00 M (-78.10%)